Skip to main content

Public Popular Chemistry Databases and Licensing


Licensing of data, and copyright is a complex thing, and always gets people hot under the collar! Some time ago, following consultation with our funders, we settled on a CC-BY-SA license for ChEMBL - this does a couple of things, but primarily it places an explicit license on the data so it is clear what you can do with it. There is a lot of hot air and active discussion over how 'public' and 'open' particular licenses are, but the CC-BY-SA 3.0 license made sense to us (for reference, this license is also used by the world's premier open resource wikipedia - here is their license)

This license we apply to each release of the database, it makes the data freely available and usable. It requires attribution, so that users of derivative works know where the data comes from, can identify the funders and producers of the work - which we think is fair and appropriate, and finally it applies 'share-alike', so that if you distribute the ChEMBL data further you shouldn't restrict the rights of your users to further give away, use, remix, etc. the data. To be clear though, it does not preclude commercial use of the data.

The Share Alike clause is the thing that people usually get excited by, but this is meant to ensure that if you distribute the data to others you make sure that you also give those you distribute it to the same right to redistribute. If you have a significant problem with this, then don't redistribute any data you get under a SA license; if you find it difficult to keep track of the provenance of data entering your systems, should you really be building stuff to distribute anyway? ;)

Chemistry is a relatively odd world compared to bioinformatics, in that users are generally worried about inadvertent disclosure of their ideas and queries - the basis of the concern is that running a search over the Internet, over an open network, can amount to disclosure and 'publication', and could in theory void a patent through prior art disclosure. As you are probably aware, it is easy to monitor and record traffic over public networks, recovering passwords, etc. Secondly, there is a general suspicion over what happens to recording usage on the servers - do the providers of the web service mine the queries? sell them on? and other sort of paranoid stuff. Well it is not as paranoid as you may think, maybe, since several large internet sites explicitly state in the Terms and Conditions that your query becomes their intellectual property. Sloppy programming, in particular with advertiser sites, can disclose a whole bunch of query data to advertisers.

One of the ways of dealing with the former issue, is to provide access over the https: protocol, this encrypts the traffic between your client browser and the server, and also prevents impersonation of the server by another machine (to most reasonable intents and purposes this is still true). The same secure http: protocol can be applied to make programmatic web services secure too.

There are a number of large 'free'/Open chemical databases at the moment, and we drew up a little table the other day comparing the license and access. It's not complete, probably contains some errors, so if anything is wrong, please let me know. If there are other Open resources to add, put something in the comments, and I'll add it to the table.

Update - thanks to Richard of the RSC, I've corrected some ambiguities in the original table.

ResourceUrl (http: protocol form)LicenseDownloadhttps:
ChEMBLhttp://www.ebi.ac.uk/chemblCC-BY-SAyesyes

BindingDBhttp://www.bindingdb.org/CC-BY-SAyesno

PubChemhttp://pubchem.ncbi.nlm.nih.gov/No clear license statementyesyes

ZINChttp://zinc.docking.org/No redistribution of significant subsets without permissionyesyes, but certificate expired

ChemSpiderhttp://www.chemspider.com/No download, and limited to a total 5,000 data entries stored locally. API access free to academic users, others by agreement.noyes, but broken

Comments

Popular posts from this blog

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Accessing SureChEMBL data in bulk

It is the peak of the summer (at least in this hemisphere) and many of our readers/users will be on holiday, perhaps on an island enjoying the sea. Luckily, for the rest of us there is still the 'sea' of SureChEMBL data that awaits to be enjoyed and explored for hidden 'treasures' (let me know if I pushed this analogy too far). See here and  here for a reminder of SureChEMBL is and what it does.  This wealth of (big) data can be accessed via the SureChEMBL interface , where users can submit quite sophisticated and granular queries by combining: i) Lucene fields against full-text and bibliographic metadata and ii) advanced structure query features against the annotated compound corpus. Examples of such queries will be the topic of a future post. Once the search results are back, users can browse through and export the chemistry from the patent(s) of interest. In addition to this functionality, we've been receiving user requests for  local (behind the

New Drug Approvals - Pt. XVII - Telavancin (Vibativ)

The latest new drug approval, on 11th September 2009 was Telavancin - which was approved for the treatment of adults with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria , including Staphylococcus aureus , both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains. Telavancin is also active against Streptococcus pyogenes , Streptococcus agalactiae , Streptococcus anginosus group (includes S. anginosus, S. intermedius and S. constellatus ) and Enterococcus faecalis (vancomycin susceptible isolates only). Telavancin is a semisynthetic derivative of Vancomycin. Vancomycin itself is a natural product drug, isolated originally from soil samples in Borneo, and is produced by controlled fermentation of Amycolatopsis orientalis - a member of the Actinobacteria . Telavancin has a dual mechanism of action, firstly it inhibits bacterial cell wall synthesis by interfering with the polymerization and cross-linking of peptid

A python client for accessing ChEMBL web services

Motivation The CheMBL Web Services provide simple reliable programmatic access to the data stored in ChEMBL database. RESTful API approaches are quite easy to master in most languages but still require writing a few lines of code. Additionally, it can be a challenging task to write a nontrivial application using REST without any examples. These factors were the motivation for us to write a small client library for accessing web services from Python. Why Python? We choose this language because Python has become extremely popular (and still growing in use) in scientific applications; there are several Open Source chemical toolkits available in this language, and so the wealth of ChEMBL resources and functionality of those toolkits can be easily combined. Moreover, Python is a very web-friendly language and we wanted to show how easy complex resource acquisition can be expressed in Python. Reinventing the wheel? There are already some libraries providing access to ChEMBL d